Moneycontrol PRO
HomeNewsIndiaIIT Kanpur develops disinfector that can sanitize a 100-sq-ft room in 15 minutes: Report

IIT Kanpur develops disinfector that can sanitize a 100-sq-ft room in 15 minutes: Report

SHUDH (Smartphone-operated Handy Ultraviolet Disinfection Helper) can be attached to a mobile vehicle, which can be operated using a smartphone

July 19, 2020 / 15:56 IST

The Indian Institute of Technology (IIT), Kanpur has come up with an ultraviolet sanitizing solution to disinfect hospitals, hotels, malls and other such high-risk places, the Business Standard has reported.

According to the report, SHUDH (Smartphone-operated Handy Ultraviolet Disinfection Helper) can disinfect a 100-sq-feet room in 15 minutes.

The prototype, according to the newspaper, can be monitored from a distance and comprises six UV lights of 15 watts each. It has been developed by a team of researchers, including Prof J Ramkumar, Amandeep Singh and Shivam Sachan at the Imagineering Laboratory at the premiere institute.

"During this pandemic situation, people are skeptical about touching papers, tables, chairs etc in the rooms, hotels, halls, hospitals etc. So we have come up with an innovation. This product can be attached to a mobile vehicle which can be operated using a smartphone. We have also developed a mobile app," Professor Ramkumar said.

"By doing some simple experiments, we have figured out that a 10X10 ft room can be disinfected in 15 minutes. The phone will help you switch the device on and off. We have used Bluetooth for the purpose," he added.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

After the outbreak of COVID-19 in India, IIT Kanpur has planned and developed several products that can help curb the spread of infection. In March, for instance, researchers at the institute were in process of developing portable ventilators significantly cheaper than the ones available in the market.

It had also created a disinfectant tunnel in May.

Moneycontrol News
first published: Jul 19, 2020 03:56 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347